RaySearch Laboratories AB (publ)
The answer first
Does RaySearch Laboratories beat the market?
No, RaySearch Laboratories has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 29% of Nordic stocks
- Quality77
- Value17
- Trend29
No. 106 of 195 in healthcare
Expectations in the price
Low expectations
For the share to return about 9% a year from today's price, the cash RaySearch Laboratories keeps must grow about 2% a year for 10 years.
Max for seven days
Follow RaySearch Laboratories with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about RaySearch Laboratories
Your first answer is free, no account needed.
Do you own RaySearch Laboratories, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with RaySearch Laboratories and a few more. Free, no card.
Super Stock+44.6%In short
- RaySearch Laboratories has fallen 20.4% over the past year, including dividends.
- Overall, RaySearch Laboratories ranks better than 29% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 54.1%. The price is 52.0% below its peak now.
Who owns RaySearch Laboratories? See the major shareholders and their stakes
What do analysts think of RaySearch Laboratories?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 29% of Nordic stocks.
No. 106 of 195 in healthcare
High A solid company: it earns well on its money and has healthy finances.
No. 63 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity1.00
- Asset turnoverSales divided by everything the company owns0.73
- Return on equityProfit divided by equity+25.4%
- Cash conversionOperating cash flow divided by profit2.08
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 109 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity7.0
- P/SPrice divided by sales4.2
- P/EPrice divided by earnings27.6
- P/CFPrice divided by operating cash flow13.3
The ranking is built on P/E, P/B and P/S.
Low Headwind in the share price: it has done worse than most over the last year.
No. 106 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months−6.3%
- 6 months−21.4%
- 9 months−7.6%
- 12 months−20.4%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own RaySearch Laboratories
24 funds we follow own RaySearch Laboratories. The share is how much of the fund the stock makes up.
- Norway1
- Sweden23
- 1 ETF
- Lannebo Hälsa och Ny Teknik ASweden · Lannebo7.1%
- Case All StarSweden · Case5.7%
- Case Gaia MicrocapSweden · Case5.0%
- TIN Småbolag ASweden · TIN4.4%
- TIN Ny Teknik FSweden · TIN3.5%
- Aktiespararna Småbolag EdgeSweden · Aktiespararna2.3%
- PLUS Hälsovård Sverige IndexSweden · PLUS1.9%
- FE Småbolag Sverige ASweden · FE Småbolag1.3%
Show all 24
- Humle SmåbolagsfondSweden · Humle1.2%
- Cicero Sverige ASweden · Cicero0.8%
- Lysa Sverige Aktier BSweden · Lysa0.7%
- Skandia Småbolag SverigeSweden · Skandia0.5%
- AMF Aktiefond SmåbolagSweden · AMF0.3%
- Kvartil Nordiska Småbolag+ Faktor ASweden · Kvartil0.3%
- Xact Svenska Småbolag (UCITS ETF)Sweden · XACT · ETF0.3%
- Skandia Småbolag Sverige Exponering ASweden · Skandia0.2%
- PLUS Småbolag Sverige IndexSweden · PLUS0.2%
- Skandia Sverige ExponeringSweden · Skandia0.1%
- Handelsbanken Norden Ind Crit (A1 NOK)Sweden · Handelsbanken0.1%
- PLUS Allabolag Sverige IndexSweden · PLUS0.1%
- Öhman Etisk Index Sverige ASweden · Öhman0.0%
- Skandia Världen SverigeSweden · Skandia0.0%
- KLP AksjeNorden IndeksNorway · KLP0.0%
- Skandia SMART FörsiktigSweden · Skandia0.0%
From the funds' latest known holdings.
About RaySearch Laboratories
RaySearch Laboratories AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 480 employees.
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems.


See the full analysis of RaySearch Laboratories.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card